5 questions about storage & shelf life.
There is no universal post-mixing shelf life. Use the exact label or pharmacy beyond-use date. CDC’s usual multidose-vial convention is an infection-control default, not evidence of chemical stability for a home-mixed peptide.
Sources: Bulk Drug Substances Used in Compounding Under Section 503A; Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks; FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss; Preventing Unsafe Injection Practices; Unused Syringes; Egrifta SV prescribing information; FDA alerts health care providers and patients to dosing errors associated with compounded injectable semaglutide products; Sterile Drug Products Produced by Aseptic Processing: Current Good Manufacturing Practice; Unapproved Drugs; Vyleesi prescribing information
There is no universal rule. Some labeled products say do not freeze; others require immediate use or room-temperature storage after mixing. Follow the exact formulation’s instructions.
Sources: Bulk Drug Substances Used in Compounding Under Section 503A; Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks; FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss; Preventing Unsafe Injection Practices; Unused Syringes; Egrifta SV prescribing information; FDA alerts health care providers and patients to dosing errors associated with compounded injectable semaglutide products; Sterile Drug Products Produced by Aseptic Processing: Current Good Manufacturing Practice; Unapproved Drugs; Vyleesi prescribing information
Follow labeled temperature, light and discard limits. Particles, cloudiness, discoloration, a damaged seal or any doubt about sterility are reasons not to use a product until the pharmacist has checked it. Clear appearance does not prove potency or sterility.
Sources: Bulk Drug Substances Used in Compounding Under Section 503A; Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks; FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss; Preventing Unsafe Injection Practices; Unused Syringes; Egrifta SV prescribing information; FDA alerts health care providers and patients to dosing errors associated with compounded injectable semaglutide products; Sterile Drug Products Produced by Aseptic Processing: Current Good Manufacturing Practice; Unapproved Drugs; Vyleesi prescribing information
Heat, freezing, light, agitation, time, container contact and diluent can matter differently by formulation. Only product-specific stability data can set storage limits.
Sources: Bulk Drug Substances Used in Compounding Under Section 503A; Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks; FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss; Preventing Unsafe Injection Practices; Unused Syringes; Egrifta SV prescribing information; FDA alerts health care providers and patients to dosing errors associated with compounded injectable semaglutide products; Sterile Drug Products Produced by Aseptic Processing: Current Good Manufacturing Practice; Unapproved Drugs; Vyleesi prescribing information
First check whether the exact medicine actually requires refrigeration and whether it must avoid freezing. Use the manufacturer’s travel guidance or ask the pharmacist; a generic ice-pack rule can freeze a product or contradict its label.
Sources: Bulk Drug Substances Used in Compounding Under Section 503A; Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks; FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss; Preventing Unsafe Injection Practices; Unused Syringes; Egrifta SV prescribing information; FDA alerts health care providers and patients to dosing errors associated with compounded injectable semaglutide products; Sterile Drug Products Produced by Aseptic Processing: Current Good Manufacturing Practice; Unapproved Drugs; Vyleesi prescribing information
← All FAQ topics | Browse all peptides
vialprep research · Sources: PubMed, FDA, peer-reviewed trials · How we verify